SLCO1B1 has been shown to play a relevant role in simvastatin-induced risk of myopathy after increasing the statin’s plasma level, without similarly affecting tolerance to atorvastatin and rosuvastatin [44,45]. The gene discussed is SLCO1B1; the disease is myopathy.